Prognose
Analytikernes gennemsnitlige kursmål er 2,73 € (+1.200,00 %). Medianen er 2,73 € (+1.200,00 %).
| Køb |
4 |
| Behold |
2 |
| Sælg |
0 |
Diskussioner i communityet
Der er endnu ingen diskussion om dette aktiv.
Start diskussionNyheder Til nyhedsfeedet
Nanox closes distribution agreement for Nanox.ARC in Costa Rica
Nanox has signed a distribution agreement with SOLME RC, S.A. for the Nanox.ARC imaging system in Costa Rica. SOLME will handle marketing, sales, installation, training and technical support and is a registered supplier of the Caja Costarricense de Seguro Social. The market rollout follows a regulatory approval process with an initial six-month proof-of-concept phase for device registration; Costa Rica is Nanox’s third Latin American market this year after Argentina and Peru. » Mere på de.investing.com
Nano-X Imaging misses Q2 2026 revenue forecast — shares plunge sharply premarket
Nano-X Imaging reported Q2 2026 revenue of $4.2 million, well below the consensus forecast of $5.54 million. GAAP net loss widened to $55.5 million, mainly due to a $40.7 million impairment. The stock fell about 19% in premarket trading and was trading near its 52-week low; cash on hand at quarter-end stood at $31.4 million. Management points to advancing system installations, initial reimbursable claims in the Nanox Imaging Network and CMS code G0680 as potential revenue support, but plans further capital raises and cost cuts. » Mere på de.investing.com
Nanox closes distribution agreement with Associated X‑Ray for New England
Nanox announced that its US subsidiary Nanox Impact has signed a distribution agreement with Associated X‑Ray Imaging for the New England region. Associated X‑Ray will market, distribute and provide support for the FDA-cleared Nanox.ARC system, using its regional presence and service infrastructure. The cooperation is part of Nanox’s strategy to expand the Nanox.ARC sales network in selected US regions. » Mere på de.investing.com
Nano-X Imaging places registered direct placement of about $8 million
Nano-X Imaging has agreed to sell 8,000,000 common shares plus warrants for up to 8,000,000 additional shares at a combined price of $1.00 per share with accompanying warrant. The warrants have an exercise price of $1.15, become exercisable after six months and expire after five years. Expected gross proceeds are about $8 million before fees; the proceeds are intended for working capital and general corporate purposes. A.G.P./Alliance Global Partners is acting as sole placement agent and the issuance will be made by prospectus supplement under the shelf registration (Form F-3). » Mere på de.investing.com
Nano‑X Imaging announces quarterly results for 31 December 2025, analysts expect revenue growth
Nano‑X Imaging will release results for the quarter ended 31 December 2025 on 20 April 2026. Four analysts on average expect EPS of -0.223 USD (prior year -0.230 USD) and revenue to increase 33% to 4.0 Mio. USD (prior year 3.0 Mio. USD). For the completed fiscal year analysts forecast on average EPS of -0.873 USD and revenues of 13.3 Mio. USD (previously 11.3 Mio. USD). » Mere på finanzen.net
Virksomhedstal
I det seneste kvartal havde Nano-X Imaging en omsætning på 3,64 mio. € og et nettoresultat på -48,62 mio. €
| (EUR) | juni 2026 | YoY |
|---|---|---|
| Omsætning | 3,64 mio. | 41,19 % |
| Bruttofortjeneste | -38,27 mio. | 1.292,11 % |
| Nettoresultat | -48,62 mio. | 289,24 % |
| EBITDA | -46,14 mio. | 371,18 % |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 18,93 mio. € |
Antal aktier | 78,75 mio. |
Højeste/laveste i 52 uger | 4,29 € - 0,19 € |
| Udbytte | Nej |
Beta | 1,36 |
P/E (PE Ratio) | -0,16 |
PEG (PEG Ratio) | 0,00 |
K/I (PB Ratio) | 0,25 |
P/S (PS Ratio) | 1,33 |
Virksomhedsprofil
Nano-X Imaging Ltd. udvikler en tomografisk billeddannelsesenhed af kommerciel kvalitet med en digital røntgenkilde. Virksomheden leverer teleradiologiske tjenester og udvikler kunstig intelligens-applikationer til brug i medicinske billeddannelsesapplikationer i den virkelige verden. Dens røntgenkilde er baseret på en digital katode i halvleder med mikro-elektro-mekaniske systemer (MEMS). Virksomheden udvikler en prototype af Nanox.ARC, et medicinsk billeddannelsessystem, der indeholder dens digitale røntgenkilde, og Nanox.CLOUD, en tilhørende cloud-baseret softwareløsning, der vil muliggøre levering af medicinske screeninger som en service. Virksomheden tilbyder også Nanox.MARKETPLACE, som forbinder billeddiagnostiske centre med radiologer og gør det muligt for radiologer at levere, og for kunder at modtage, fjernfortolkninger af billeddata; kunstig intelligens (AI)-baserede softwareløsninger til billeddannelse til hospitaler, sundhedsforsikringsselskaber (HMO'er), integrerede leveringsnetværk, farmaceutiske virksomheder og forsikringsselskaber, der er designet til at identificere eller forudsige udiagnosticerede eller underdiagnosticerede medicinske tilstande gennem analyse af data i billeder fra eksisterende computertomografiscanninger for osteoporose og hjerte-kar-sygdom; Teleradiologiske tjenester, som leverer billeddiagnostiske fortolkningsydelser til radiologiske praksisser, hospitaler, lægeklinikker, diagnostiske billeddannelsescentre, akutklinikker og multispecialiserede lægegrupper, kontrakter og radiologiske aflæsninger. Virksomheden blev grundlagt i 2011 og har hovedkontor i Neve Ilan, Israel.
| Navn | Nano-X Imaging |
| CEO | Erez I. Meltzer |
| Hjemsted | Petah Tikva,
Israel |
| Websted | |
| Sektor | Sundhed |
| Branche | Sundhedsudstyr og -produkter |
| Børsnotering | 21.08.2020 |
| Medarbejdere | 197 |
Tickersymboler
| Børs | Symbol |
|---|---|
NASDAQ | NNOX |